Even though discount cards might help reduce the stress of higher drug expenditures during the short term, they do not handle the systemic difficulties driving up prescription rates while in the U.S. Broader policy alterations could deal with the foundation results in of soaring drug rates, for instance lack of transparency in pricing plus the role